Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $9.7 million.

  • Iradimed's Operating Expenses rose 1497.12% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.2 million, marking a year-over-year increase of 1045.78%. This contributed to the annual value of $34.4 million for FY2024, which is 1414.99% up from last year.
  • As of Q3 2025, Iradimed's Operating Expenses stood at $9.7 million, which was up 1497.12% from $9.2 million recorded in Q2 2025.
  • In the past 5 years, Iradimed's Operating Expenses ranged from a high of $9.7 million in Q3 2025 and a low of $5.3 million during Q1 2021
  • In the last 5 years, Iradimed's Operating Expenses had a median value of $7.2 million in 2023 and averaged $7.4 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first tumbled by 3017.02% in 2021, then skyrocketed by 2235.83% in 2023.
  • Iradimed's Operating Expenses (Quarter) stood at $6.1 million in 2021, then grew by 13.46% to $7.0 million in 2022, then increased by 18.47% to $8.3 million in 2023, then grew by 8.57% to $9.0 million in 2024, then grew by 7.81% to $9.7 million in 2025.
  • Its Operating Expenses was $9.7 million in Q3 2025, compared to $9.2 million in Q2 2025 and $9.4 million in Q1 2025.